Cargando…
Analysis of the clinical indications for opiate use in inflammatory bowel disease
BACKGROUND/AIMS: Opiate use for inflammatory bowel disease (IBD), particularly high-dose (HD) use, is associated with increased mortality. It's assumed that opiate use is directly related to IBD-related complaints, although this hasn't been well defined. Our goal was to determine the indic...
Autores principales: | Gao, Youran, Khan, Sundas, Akerman, Meredith, Sultan, Keith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association for the Study of Intestinal Diseases
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323312/ https://www.ncbi.nlm.nih.gov/pubmed/28239317 http://dx.doi.org/10.5217/ir.2017.15.1.83 |
Ejemplares similares
-
Clinical Markers of Crohn’s Disease Severity and Their Association With Opiate Use
por: Cheung, Mary, et al.
Publicado: (2015) -
Combination therapy for inflammatory bowel disease
por: Sultan, Keith S, et al.
Publicado: (2017) -
Declining use of combination infliximab and immunomodulator for inflammatory bowel disease in the community setting
por: Berkowitz, Joshua C, et al.
Publicado: (2018) -
The impact of corticosteroid use on inpatients with inflammatory bowel disease and positive polymerase chain reaction for Clostridium difficile
por: Lim, Huei-Wen, et al.
Publicado: (2019) -
Some Contra-Indications for the Use of Opiates
por: Werner, Marie B.
Publicado: (1892)